✦ LIBER ✦

Considerations in the Design of Preclinical Safety Evaluation Programs for Novel Therapeutics Used in Neurologic Diseases

✍ Scribed by J. A. CAVAGNARO; S. LIU

Book ID: 119871458
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 49 KB
Volume: 765
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1995.tb16600.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical Safety Evaluation of Biophar

Preclinical Safety Evaluation of Biopharmaceuticals || Use of Animal Models of Disease in the Preclinical Safety Evaluation of Biopharmaceuticals

✍ Cavagnaro, Joy A. 📂 Article 📅 2008 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 210 KB

the Goal Is To Provide A Comprehensive Reference Book For The Preclinicaldiscovery And Development Scientist Whose Responsibilities Span Target Identification, Lead Candidate Selection, Pharmacokinetics, Pharmacology, And Toxicology, And For Regulatory Scientists Whose Responsibilities Include The E

Practical Considerations for the Design

Practical Considerations for the Design and Evaluation of Disease Education and Management Programs in the Workplace

✍ Dr Seth Serxner MPH, PhD, Dr David Anderson PhD 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 105 KB

Pharmaceutical Sciences Encyclopedia (Dr

Pharmaceutical Sciences Encyclopedia (Drug Discovery, Development, and Manufacturing) || Use of Animal Models of Disease in the Preclinical Safety Evaluation of Biopharmaceuticals

✍ Gad, Shayne Cox 📂 Article 📅 2010 🏛 John Wiley & Sons, Inc. ⚖ 125 KB

Angiotensin-converting enzyme inhibition

Angiotensin-converting enzyme inhibition in mild hypertension with concomitant diseases and therapies: An efficacy, safety, and compatibility study of novel design, the perindopril therapeutic safety study

✍ Klaus O. Stumpe; Axel Overlack 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Considerations for the sensible use of r

Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic

✍ Heather A. Arnett; Joanne L. Viney 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Use of transgenic models in the evaluati

Use of transgenic models in the evaluation of novel therapeutic for Alzheimer's disease: S. Bellosta Institute of Pharmacological Sciences, University of Milan

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 152 KB